Most Recent Articles by Lea Eslava-Kim
The FDA granted Breakthrough Therapy designation to Synthetic Biologics' ribaxamase SYN-004 for Clostridium difficile infection prevention.
Zolyd (fosfomycin for injection) was found to be safe and generally well-tolerated, mostly with mild and transient treatment emergent adverse events reported.
Paratek announced positive outcomes for their phase 3 trial of omadacycline for treating community-acquired bacterial pneumonia.
The FDA has granted Qualified Infectious Disease Product (QIDP) to D-PLEX (Doxycycline/Polymer-Lipid Encapsulation Matrix; PolyPid), a secured antibiotic drug reservoir for the local prevention and treatment of surgical infections.
FDA has granted Orphan Drug designation to the recombinant rF1V plague vaccine for pre-exposure prophylaxis of Yersinia pestis infection, also known as, the plague.
More Articles by Lea Eslava-Kim
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Practical Tips to Improve HIV/AIDS Medication Adherence
- Threat of Zika Virus Still Significant in California
- Protective Role of Pre-F Antibodies Against RSV Acute Respiratory Infection
- HCV Neuropsychiatric Symptoms Likely Linked to Virus' Effects on Brain Function
- Prenatal Tdap Vaccination Not Associated With an Increased Risk of Autism
- Evaluation of Appropriateness of Ceftriaxone Use in the Emergency Department
- Risk Factors for Prosthetic Joint Infection Increase Likelihood for Surgical Revision
- CDC: Increase in Rate of STDs for Fourth Consecutive Year in the United States
- Effect of Respiratory Tract Microbiome on Susceptibility to Viral Infections
- Gram-Negative Bacteria Antibiotic Susceptibility for Pneumonia in the ICU
- Food Insecurity Associated With Substance Use in Women Infected With HIV
- Penicillin Allergies: Commonly Reported but Rarely Accurate
- Neisseria Meningitidis Serogroup W Infections Increasing in Georgia
- Cardiac Changes Linked With Specific ARVs in Perinatally Acquired HIV
- Physical Activity Associated With Cognitive Benefits in Women Living With HIV